143 related articles for article (PubMed ID: 6460820)
1. Modulation of chronic lymphocytic leukemia cells by phorbol ester: increase in Ia expression, IgM secretion and MLR stimulatory capacity.
Okamura J; Letarte M; Stein LD; Sigal NH; Gelfand EW
J Immunol; 1982 May; 128(5):2276-80. PubMed ID: 6460820
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
[TBL] [Abstract][Full Text] [Related]
3. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
[TBL] [Abstract][Full Text] [Related]
4. A phorbol ester tumor promoter induces changes in the expression of immunoglobulins and DR antigens in human lymphoblastoid cells.
Roth P; Halper JP; Weinstein IB; Pernis B
J Immunol; 1982 Aug; 129(2):539-44. PubMed ID: 6979576
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of human Ia antigens by chronic lymphocytic leukemia cells following treatment with 12-O-tetradecanoylphorbol-13-acetate.
Guy K; Van Heyningen V; Dewar E; Steel CM
Eur J Immunol; 1983 Feb; 13(2):156-9. PubMed ID: 6403357
[TBL] [Abstract][Full Text] [Related]
6. Phorbol ester-induced differentiation of a non-T, non-B leukemic cell line: model for human lymphoid progenitor cell development.
LeBien TW; Bollum FJ; Yasmineh WG; Kersey JH
J Immunol; 1982 Mar; 128(3):1316-20. PubMed ID: 7035564
[TBL] [Abstract][Full Text] [Related]
7. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
Guy K; Meehan RR; Dewar AE; Larhammar D
Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
[TBL] [Abstract][Full Text] [Related]
8. Alterations in cell surface phenotype of T- and B-cell chronic lymphocytic leukemia cells following in vitro differentiation by phorbol ester.
Shawler DL; Glassy MC; Wormsley SB; Royston I
J Natl Cancer Inst; 1984 May; 72(5):1059-63. PubMed ID: 6609264
[TBL] [Abstract][Full Text] [Related]
9. Response of non-T, non-B acute lymphocytic leukemia cells to phorbol ester.
Okamura J; Gelfand EW; Letarte M
Cancer Res; 1984 Mar; 44(3):1246-51. PubMed ID: 6581867
[TBL] [Abstract][Full Text] [Related]
10. Ecto-5'-nucleotidase. II. Effect of 12-O-tetradecanoylphorbol 13-acetate on the expression of enzyme in normal and neoplastic B-cell lines.
Hibi T; SenGupta S; MacKay A; Gelfand EW; Chechik BE
J Natl Cancer Inst; 1984 Nov; 73(5):1081-5. PubMed ID: 6092766
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic modulation of chronic lymphocytic, prolymphocytic, and lymphoplasmacytic leukemia cells by TPA: induction of TRAP isoenzyme 5 and HD6 (CD22) antigen and enhancement of IgM messenger RNA.
Thiel E; Pachmann K; Dörken B; Gaedicke G; Ziegler-Heitbrock HW
Blood Cells; 1987; 12(2):365-83. PubMed ID: 3476168
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of the response of chronic lymphocytic leukemia cells to phorbol ester.
Okamura J; Gelfand EW; Letarte M
Blood; 1982 Nov; 60(5):1082-8. PubMed ID: 6215075
[TBL] [Abstract][Full Text] [Related]
13. Phorbol ester (TPA)-induced surface membrane alterations in B-type hairy cell and lymphocytic leukemia cells.
Polliack A; Gurfel D; Leizerowitz R; Feinstein H; Gazitt Y
Scan Electron Microsc; 1986; (Pt 4):1523-35. PubMed ID: 3810025
[TBL] [Abstract][Full Text] [Related]
14. Phorbol ester enhances both interleukin 2 receptor expression and immunoglobulin secretion in human Epstein-Barr virus-immortalized B cells.
Polke CR; Lowenthal JW; Roth SA; Rohwer P; MacDonald HR; Kalden JR
Eur J Immunol; 1986 Feb; 16(2):146-50. PubMed ID: 3007165
[TBL] [Abstract][Full Text] [Related]
15. [Induced differentiation of subpopulations of leukemic blood cells in patients with chronic B-cell lympholeukemia].
Zlobina EN; Baryshnikov AIu
Biull Eksp Biol Med; 1987 Mar; 103(3):340-2. PubMed ID: 3548840
[TBL] [Abstract][Full Text] [Related]
16. Phorbol ester induction of plasmacytoid and hairy cell leukemia features in B-type lymphocytic leukemias: the relation to B-cell differentiation and maturation.
Gazitt Y; Polliack A
Blood Cells; 1987; 12(2):413-39. PubMed ID: 3497682
[TBL] [Abstract][Full Text] [Related]
17. Immune phenotype and some enzyme patterns in phorbol ester-induced chronic lymphocytic leukemia cells.
Babusíková O; Mesárosová A; Kusenda J; Koníková E; Klobusická M; Hrivnáková A
Neoplasma; 1995; 42(5):221-6. PubMed ID: 8552199
[TBL] [Abstract][Full Text] [Related]
18. Changes in the expression of B cell surface markers on complement receptor-positive and complement receptor-negative B cells induced by phorbol myristate acetate.
Lindsten T; Thompson CB; Finkelman FD; Andersson B; Scher I
J Immunol; 1984 Jan; 132(1):235-9. PubMed ID: 6361121
[TBL] [Abstract][Full Text] [Related]
19. Initiator and promoter induced specific changes in epidermal function and biological potential.
Yuspa SH; Hennings H; Lichti U
J Supramol Struct Cell Biochem; 1981; 17(3):245-57. PubMed ID: 7328673
[TBL] [Abstract][Full Text] [Related]
20. Deficient expression of MHC class II antigens in some cases of human B cell leukaemia.
Guy K; Docherty LJ; Dewar AE
Clin Exp Immunol; 1986 Feb; 63(2):290-7. PubMed ID: 3486060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
